Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - calcium as calcium carbonate; calcium as calcium gluconate; dicalcium phosphate dihydrate; vitamin a acetate = retinyl acetate; biotin-d; vitamin d3 = cholecalciferol; manganese sulfate monohydrate; ferric pyrophosphate; magnesium sulfate dried; zinc oxide; ammonium chloride - oral powder, pre-mix - calcium as calcium carbonate mineral-calcium-salt active 258.0 g/kg; calcium as calcium gluconate mineral-calcium-salt active 4.65 g/kg; dicalcium phosphate dihydrate mineral-calcium-salt active 46.0 g/kg; vitamin a acetate = retinyl acetate vitamin-a active 90.0 mg/kg; biotin-d vitamin-b complex active 250.0 mg/kg; vitamin d3 = cholecalciferol vitamin-d3 active 5.0 mg/kg; manganese sulfate monohydrate ungrouped other 2.0 g/kg; ferric pyrophosphate mineral-iron other 5.0 g/kg; magnesium sulfate dried mineral-magnesium other 25.0 g/kg; zinc oxide mineral-zinc other 2.0 g/kg; ammonium chloride ammonium other 5.0 g/kg - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

Ierland - Engels - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - calcium acetate - tablet - 500 milligram(s) - calcium; calcium acetate anhydrous

Malta - Engels - Malta Medicines Authority

sanofi malta limited - calcium polystyrene sulfonate - powder for oral suspension - calcium polystyrene sulfonate 99.934 % (w/w) - mineral supplements

Malta - Engels - Malta Medicines Authority

hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products

Malta - Engels - Malta Medicines Authority

hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products

Malta - Engels - Malta Medicines Authority

hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products

Verenigde Staten - Engels - NLM (National Library of Medicine)

bausch health us, llc - edetate calcium disodium (unii: 25ih6r4sgf) (edetic acid - unii:9g34hu7rv0) - edetate calcium disodium 200 mg in 1 ml - edetate calcium disodium is indicated for the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults. chelation therapy should not replace effective measures to eliminate or reduce further exposure to lead. edetate calcium disodium should not be given during periods of anuria, nor to patients with active renal disease or hepatitis.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 100 mg/10ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 1000 mg/100ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 200 mg/20ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists